Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications
Gene- and immune-targeted therapy combinations using dual-matched biomarkers for patient selection.
Journal: NPJ precision oncology
Published: March 28, 2025
Ag(e)nostic precision oncology therapy approvals across the years.
Journal: Trends in cancer
Published: March 04, 2025
Tumour-agnostic kinase inhibitors.
Journal: Nature reviews. Drug discovery
Published: January 28, 2025
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 14, 2025
Lessons learned from a decade of immune checkpoint inhibition: The good, the bad, and the ugly.
Journal: Cancer metastasis reviews
Published: October 23, 2024
If it is a solid tumor target, then it may be a hematologic cancer target: Bridging the great divide.
Journal: Med (New York, N.Y.)
Published: April 26, 2024
Reverse repurposing: Potential utility of cancer drugs in nonmalignant illnesses.
Journal: Med (New York, N.Y.)
Published: March 01, 2024
Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia.
Journal: NPJ precision oncology
Published: February 26, 2024
If it's a target, it's a pan-cancer target: Tissue is not the issue.
Journal: Cancer treatment reviews
Published: January 21, 2024
Considering molecular alterations as pan-cancer tissue-agnostic targets.
Journal: Nature cancer
Published: December 15, 2023
Last Updated: 09/26/2026